{"entity":{"id":"protecthealth-malaysia","kind":"institution","name":"ProtectHealth Corporation","aka":["ProtectHealth","ProtectHealth Corporation Sdn Bhd","ProtectHealth Malaysia","PeKa B40","PeKa Sihat"],"tldr":"A not-for-profit company owned by Malaysia's Ministry of Health that runs health financing schemes for the government, including PeKa Sihat for lower-income Malaysians aged 40 and over, which pays an incentive of RM1,000 for completing cancer treatment.","summary":"ProtectHealth Corporation Sdn Bhd was incorporated on 19 December 2016 as a wholly owned, not-for-profit subsidiary of ProtectHealth Malaysia, established under the Ministry of Health, with mandates in national health financing and strategic purchasing. Its own slides give its roles: administrator of the Skim Peduli Kesihatan untuk Kumpulan B40 (PeKa B40, now PeKa Sihat) from 15 April 2019, and of the Skim Perubatan MADANI pilot from 5 May 2023.\n\nPeKa Sihat is for Malaysian citizens in the B40 lower-income group: recipients of Sumbangan Tunai Rahmah and their registered spouses aged 40 and over qualify automatically. After a health screening, benefits include medical equipment worth up to RM20,000, an incentive of RM1,000 for completing cancer treatment in a Ministry of Health hospital, and a transport allowance of up to RM500 in the peninsula or RM1,000 in Sabah, Sarawak and Labuan.\n\nIn 2026 it ran the tender for a Cancer Drug List for the base Medical Health Insurance and Takaful (MHIT) product: a positive list of cancer medicines for private insurance, built on the Ministry of Health Medicines Formulary's dossier concepts, with cost-sharing categories and referral pathways to public oncology services when a policyholder reaches the cover limit. The tender was released on 3 April 2026, with a contract planned for May to November 2026. Its office is in Century Square, Cyberjaya; the coordinates are a Cyberjaya centroid.","asOf":"2026-11-04","links":[{"label":"ProtectHealth: PeKa Sihat (Malay)","url":"https://protecthealth.com.my/peka-sihat/"},{"label":"ProtectHealth: Cancer Drug List for the base MHIT product, open day slides (2026, PDF)","url":"https://protecthealth.com.my/wp-content/uploads/2026/04/Open-Day-MHIT.pdf"},{"label":"ProtectHealth: contact","url":"https://protecthealth.com.my/contact/"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ministry-of-health-malaysia","national-cancer-society-malaysia"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-kimman-action-catastrophic-expenditure-southeast-asia-bmc-med-2015"],"journals":[],"dependsOn":[],"notes":[],"city":"Cyberjaya","country":"MY","lat":2.922,"lng":101.65,"institutionType":"government","website":"https://protecthealth.com.my","programs":["PeKa Sihat (formerly PeKa B40): screening and cancer treatment completion incentive","Skim Perubatan MADANI","Cancer Drug List for the base MHIT product (tender 2026)"]},"route":"/institutions/protecthealth-malaysia/","neighbours":{"institution":[{"id":"ministry-of-health-malaysia","kind":"institution","name":"Ministry of Health Malaysia","route":"/institutions/ministry-of-health-malaysia/"},{"id":"national-cancer-society-malaysia","kind":"institution","name":"National Cancer Society of Malaysia","route":"/institutions/national-cancer-society-malaysia/"}],"paper":[{"id":"paper-kimman-action-catastrophic-expenditure-southeast-asia-bmc-med-2015","kind":"paper","name":"Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries","route":"/key-papers/paper-kimman-action-catastrophic-expenditure-southeast-asia-bmc-med-2015/"}]}}